UNSPSC 51152068: Pipecuronium bromide

This classification denotes a muscle relaxant with the molecular formula C35H62N4O4.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R6ZTY81RE1, chemically known as 4,4-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1,1-dimethylpiperazinium)dibromide, diacetate (ester) but more generally known as pipecurium bromide, which bears US NIH Compound Identifier 65332. European Medicines Agency schedules Pipecuronium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14880MIG.

UNSPSC 51152068 Pipecuronium bromide is a Commodity code nominally for a specific pharmaceutical agent, but the recent state and local procurement activity tagged under it shows a significant mismatch: Seminole County, Florida posted an IFB on June 30, 2026 for the purchase of Naloxone and Safe Drug Deactivation Systems, neither of which falls within the scope of pipecuronium bromide. The county solicitation reflects community health and opioid-response procurement, not neuromuscular blocking agent supply. This mismatch suggests the code may have been applied in error by the jurisdiction or the opportunity was incorrectly tagged in the data source. The recent activity does not support a reliable characterization of what state and local governments are actually buying under this Commodity code for pipecuronium bromide itself.

The single identified opportunity under this code—Seminole County's IFB60459723LAS—calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid deadline was July 26, 2023, with electronic submission required through the county's e-Procurement Portal. Vendors must provide unit costs, maintain drug-free workplace and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract includes a two-year initial term with a one-year renewal option and is potentially funded through FEMA. Without additional recent opportunities correctly aligned to pipecuronium bromide procurement, the code shows insufficient current activity to support reliable market characterization or issuing-body profiling at the state and local level.